Philadelphia doctor weighs in on Kate Middleton’s cancer diagnosis
The announcement sparked an outpouring of support and comes as her father-in-law, King Charles, King Charles, also undergoes cancer treatment.
The announcement sparked an outpouring of support and comes as her father-in-law, King Charles, King Charles, also undergoes cancer treatment.
Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women…
Cancer recurrences are poorly recorded within electronic health records around the world. This hinders research into the efficacy of cancer treatments. Currently, the retrospective identification…
Dima El-Sharkawi, MBBS, MA, PhD, MRCP, FRCPath, The Royal Marsden NHS Foundation Trust, London, UK, briefly summarizes the current treatment landscape for patients with T-cell…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
Concurrent radical cystectomy and extended lymph node dissection did not show benefit vs standard lymph node dissection in muscle invasive urothelial cancer.
Outcome improvements with lutetium Lu 177 vipivotide tetraxetan vs ARPI change favored prior treatment with abiraterone vs enzalutamide in mCRPC.
TAR-200 displayed a high complete response rate in Bacillus Calmette–Guérin-unresponsive high-risk non–muscle-invasive bladder cancer.
James Allison, Ph.D., is co-leader of the Immunotherapy Moon Shot platform at MD Anderson Cancer Center. He was recently named one of TIME’s 100 most…
A real-world study found adding a PD-L1 inhibitor to cabozantinib offered no significant survival advantage for patients with metastatic kidney cancer who had already received…